Compositions and methods for the therapy and diagnosis of influenza

Details for Australian Patent Application No. 2008321016 (hide)

Owner Spaltudaq Corporation

Inventors Olsen, Ole; Cox, Thomas; King, Gordon; Mitcham, Jennifer; Grandea, Andres G.

Agent Cullens

Pub. Number AU-A-2008321016

PCT Pub. Number WO2009/064805

Priority 61/053,840 16.05.08 US; 61/095,208 08.09.08 US; 60/987,353 12.11.07 US; 60/987,355 12.11.07 US

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/064805 Priority application(s): WO2009/064805

17 June 2010 Alteration of Name

  The name of the applicant has been altered to Theraclone Sciences, Inc.

25 November 2010 Amendment Made

  The nature of the amendment is: Add co-inventor Moyle, Matthew

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321026-Production of cytotoxic antibody-toxin fusion in eukaryotic algae

2008321009-Accommodative intraocular lens system